Adult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016

Similar documents
MONTEFIORE MEDICAL CENTER

Adult Institutional Pharmacokinetics Protocol

SBUH Aminoglycoside Dosing Protocol

VANCOMYCIN DOSING AND MONITORING GUIDELINES

(Max 2 g) = to nearest 250 mg

IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE:

Policy: Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW:

TDM of Aminoglycoside Antibiotics

BSWH Pharmacist Continuing Education PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin

Adult Dose. Adults Day 1: 1mg/kg daily Day 2: 2mg/kg daily Day 3 onwards: 3mg/kg daily. Where appropriate consider rounding dose to nearest 50mg.

Drug Typical Dose CrCl (ml/min) Dose adjustment for renal insufficiency Acyclovir PO (HSV) 400 mg TID >10 <10 or HD PD

Antimicrobial Reference Laboratory

Approved by: SMG Origination Date: 06/14 Expiration Date: 06/17 Review Date: Revision Date: POLICY and PROCEDURE Archived Date: Page 1 of 14

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control

Antimicrobial Reference Laboratory

D DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2

AMINOGLYCOSIDES DOSING AND MONITORING GUIDELINES

Both adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) 45 (52% of 87 members) 29 (47% of 62 members)

Initiating Aminoglycosides Safely. Last updated: July 2016, Version 5 Questions/Comments?

Clinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)

Antimicrobial Stewardship: A System- Wide Approach at Carolinas HealthCare System

IV 5 mg/kg q12h 5 mg/kg q24h 2.5 mg/kg q24h mg/kg q24h (post HD) 50% standard dose q24h 5 mg/kg q24h. IV 5-10 mg/kg q12h

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS

ADULT ANTIMICROBIAL DOSING TOOL (NB Provincial Health Authorities Anti-Infective Stewardship Committee, September 2017)

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults

Vancomycin Pharmacokinetics. Myrna Y. Munar, Pharm.D., BCPS Associate Professor of Pharmacy

Diane M. Gomes, Pharm.D. Outcomes in Antimicrobial Stewardship Post-Doctoral Pharmacy Fellow Providence Veterans Affairs Medical Center

D DAVID PUBLISHING. Evaluation of the Effectiveness of a Vancomycin Nomogram at Predicting Trough Levels within a Therapeutic Range. 1.

Is the package insert correct? PK considerations

Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review

Continuous Infusion of Antibiotics In The ICU: What Is Proven? Professor of Medicine Vice-Chairman, Department of Medicine SUNY at Stony Brook

Stanford Health Care Last Review Date: 8/2016 Pharmacy Department Policies and Procedures

NHS Grampian Staff Guidance for the Administration of Intravenous Vancomycin in Adults via Intermittent (pulsed) Infusion

THE AMINOGLYCOSIDE ANTIBIOTICS

MEDICATION MONITORING: Pharmacist-Managed Intravenous (IV) Vancomycin Protocol

December 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide

AMINOGLYCOSIDES TDM D O N E B Y

Clinical Study Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations

The antibiotic dose and the obese ICU patient

Lessons from recent studies. João Gonçalves Pereira UCIP DALI

A Snapshot of Colistin Use in South-East Europe and Particularly in Greece

Medication Dosing in CRRT

Vancomycin: Class: Antibiotic.

Aminoglycosides John A. Bosso, Pharm.D.

Clinical Safety & Effectiveness Cohort # 10

Challenges in Therapeutic Drug Monitoring:

Evaluation of Vancomycin Continuous Infusion in Trauma Patients

PK/PD degli antibiotici utilizzati nella sepsi

May 11, Ceftriaxone for MSSA. Daptomycin Dosing Weight. Candidiasis Treatment

EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING

Pneumonia Community-Acquired Healthcare-Associated

Index. Note: Page numbers of article titles are in boldface type.

SHC Vancomycin Dosing Guide

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator

Orchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department

PHA Spring First Exam. 8 Aminoglycosides (5 points)

Mortality Rate was unsightly!!! 4/24/2013. Sepsis Quality Improvement Project

2/6/14. What s Hot in ID Objectives

Other β-lactam. A. Carbapenems:

Counties in the top and bottom two quintiles of both diabetes and obesity, Age-adjusted percentage of adults aged 20 years who are obese, 2007

PPP 1. Continuation, modification, and discontinuation of a medication

Aminoglycosides. Uses: Treatment of serious gram-negative systemic infections and some grampositive

PHARMACOKINETIC & PHARMACODYNAMIC OF ANTIBIOTICS

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro

University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology

Cystic Fibrosis: Pulmonary Exacerbations Management Guidelines

CLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel

Sep Oct Nov Dec Total

Experience with a Once-Daily Aminoglycoside Program Administered to 2,184 Adult Patients

The Challenge of Managing Staphylococcus aureus Bacteremia

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

Optimizing antifungal dosing regimens. Joseph Meletiadis, PhD, FECMM Assistant Professor of Microbiology

Should we be performing TDM in seriously ill patients with Gram negative infections?

MICHIGAN MEDICINE GUIDELINES FOR TREATMENT OF URINARY TRACT INFECTIONS IN ADULTS

Infections Amenable to OPAT. (Nabin Shrestha + Ajay Mathur)

Alternative Dosing for IV Antibiotics

Evaluation of Vancomycin Dosing and Corresponding Drug Concentrations in Pediatric Patients

PALO VERDE HEALTH CARE DISTRICT REGULAR BOARD OF DIRECTORS MEETING MINUTES July 27, 2016 City Council Chambers

Joint Trust Guideline for the Use of Intravenous Vancomycin in Paediatrics

Effect of piperacillin/tazobactam restriction on usage and rates of acute renal failure

Giving the Proper Dose: How Can The Clinical and Laboratory Standards Institute(CLSI)Help?

Annual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2016

GUIDELINES FOR USERS ANTIMICROBIAL REFERENCE LABORATORY ASSAY SERVICE. 17th Edition

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

Antibiotic Dosing in the Elderly

Chapter 5 ~ Infections

Cubicin A Guide to Dosing

PHA5128 Dose Optimization II Case Study 3 Spring 2013

Shaukat Khanum Memorial Cancer Hospital and Research Center. Volume V, Issue # 1, 2015

Healthy Adult cuti Patient. Cmax (mcg/ml)(mean ± SD) 73.7 ± ± 113. Vd (L)(mean ± SD) 17.9 ± ± 12.1

UPDATE ON FEBRILE NEUTROPENIA

Outline of presentation. Pinyo Rattanaumpawan; Sajja Supornpun; Basic Concepts of ASP Research to Practice in ASP ASP Siriraj

Abstract. Background. Editor: M. Grobusch

Optimizing Antibiotic Therapy in the ICU For Pneumonia Current and Future Approaches

Neutropenic Sepsis Guideline

Cystatin C: A New Approach to Improve Medication Dosing

Use of Antibacterial Agents in Renal Failure

Intravenous Vancomycin Use Adult Inpatient/Ambulatory Clinical Practice Guideline

Transcription:

Adult Inpatient Antibiogram Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates January to December 2016 Department of Pathology Camille Hamula, PhD Director, Clinical Microbiology Laboratory Department of Medicine, Division of Infectious Diseases Judith Aberg, MD Chief, Infectious Diseases Gopi Patel, MD MS Director, Antimicrobial Stewardship Program Hospital Epidemiologist Meena Rana, MD Associate Director, Antimicrobial Stewardship Program Department of Pharmacy Joanne Meyer, MS PharmD Chief Pharmacy Officer, Mount Sinai Health System Patricia L. Saunders-Hao, PharmD Gargi Patel, PharmD Polina Lerner, PharmD ID Clinical Pharmacists, Antibiotic Stewardship Program Contact Information: Microbiology Ext. 88168 Infection Prevention Ext. 89450 Antibiotic Approval Pager 9407

Agent (avg. cost/day) Dosing Recommendations Based on Renal Function Estimated CrCl (ml/min) >50 30-50 10-30 <10 Supplement for HD/CAPD/CVVH/CAVH Ampicillin/ sulbactam ($14) Aztreonam ($198) Cefazolin ($9) Cefepime ($21) Colistin 2 ($18) Daptomycin 3 ($260) Ertapenem ($90) Fluconazole 4 ($3 IV/ $ 3 PO) Imipenem/ cilastatin ($40) Levofloxacin ($3 IV/ $0.37 PO) Meropenem ($30) Piperacillin/ tazobactam ($40) q8-12h 5 in 2-3 1g IV 200 400 mg 500 750 mg 1-2g IV 3.375-4.5 g IV 2.5 3.8 in 2 mg/kg IV 1 g IV 500-750 mg 1-2g IV 1-2g IV 1.5 in 2 0.5g IV 750 mg x1, then 500 mg (CrCl < 20) 0.5 1g IV 1-2g IV 1g IV or 2g IV 0.5g - 1g IV 1.5 mg/kg IV q36h 2 0.5g IV 250 mg IV 750 mg x1, then 250-500 mg 0.5-1g IV CAPD: 3g IV CVVH/CAVH: 3g IV q8-12h, Extra 0.5g AD 1 CVVH/CAVH: CAPD: 500mg IV CVVH/CAVH: 1-2g IV CAPD: 1-2 g IV CVVH/CAVH: 1-2g 1 HEMO: 2.5 mg/kg AD CVVH: 2.5 divided in 2 doses HEMO (MWF or TThSa): 6 mg/kg post HD for 2 sessions; 9mg/kg post HD for 3 rd session HEMO (PRN): 6mg/kg post HD CAPD: mg/kg CVVH: mg/kg ; if dosed <6 hrs prior to HD, give 150 mg supplement AD* HEMO: 100% of dose AD 1 CAPD: 100 200 mg CVVH: 200 400 mg HEMO: CAPD: 250 mg IV CVVH/CAVH: 500mg IV CVVH/CAVH: 500-750 mg CVVH/CAVH: 1g CVVH/CAVH: 2.25 3.375g IV 1 AD= after dialysis; Antibiotics should be dosed after dialysis on HD days. If dose is given right before HD, then a supplemental dose may be required. 2 Always consider using loading dose on day one: 5 x IBW (max of 300mg); wait 24hrs before giving next dose 3 Dosing (6-12mg/kg) depends on severity and pathogen consult ID 4 Consider loading dose (12mg/kg max) for treatment of invasive candidiasis infections FORMULARY ANTIMICROBIAL AGENTS REQUIRING APPROVAL AT ALL TIMES (24/7) Acyclovir IV (pediatrics only) Foscarnet Voriconazole Amphotericin B Isavuconazole Caspofungin Linezolid Antimalaria medications: Ceftaroline Pentamidine inhaled - Atovaquone/proguanil Cidofovir Polymyxin B - Primaquine Colistin Posaconazole - Quinidine IV (if for malaria) Cytomegalovirus IVIG Tigecycline - Quinine Daptomycin Varicella Zoster IVIG

VANCOMYCIN DOSING CrCl (ml/min) Vancomycin Dosing > 70 ml/min 15 mg/kg every 8-12 40 69 ml/min 15 mg/kg every 12-24 20 39 ml/min 15 mg/kg every 24-48 <20 ml/min 15 mg/kg x 1, then re-dose by level HD/CAPD CVVH 15 mg/kg x 1, then re-dose by level 1 g IV every 24 Doses are based on actual body weight Doses should be rounded to the nearest 250 mg (maximum 2 g per dose) Consultation with an Infectious Disease specialist is strongly recommended for Staphylococcus aureus bacteremia (irrespective of source and susceptibilities) Am J Health-Syst Pharm. 2009; 66:82-98 VANCOMYCIN MONITORING Trough serum concentrations are the most accurate and practical method for monitoring efficacy and avoiding adverse effects Troughs should be obtained just prior to the next dose when patient at steady-state (usually before 4 th or 5 th dose) o Minimum serum trough levels should always be maintained > 10 mg/l o Minimum serum trough levels of 15-20 mg/l are recommended for complicated infections (endocarditis, osteomyelitis, meningitis, and staphylococcal pneumonia)

ADULT AMINOGLYCOSIDE DOSING Once daily dosing of aminoglycosides is recommended for the treatment of Gram-negative infections. An Infectious Diseases (ID) or ID Pharmacist consultation is recommended. Exclusions to Once Daily Dosing Avoid aminoglycosides in neuromuscular disease Traditional dosing is preferred for: o CrCl < 20ml/min or HD o Burns (involving >20% BSA) o Pregnancy o Significant ascites or patients with significant third spacing Calculating Dose Dosing is based on Ideal Body Weight (IBW) In obese patients (>120% IBW) use Adjusted Body Weight (ABW) o ABW= IBW + 0.4(actual body weight IBW) If actual body weight is under IBW, use actual body weight CrCl (ml/min) Aminoglycoside Once Daily Initial Dose Gentamicin OR > 60 7 mg/kg every 24 15 mg/kg every 24 40 to 59 7 mg/kg every 36 15 mg/kg every 36 20-39 7 mg/kg every 48 15 mg/kg every 48 <20 or HD Use traditional AG dosing protocol

ONCE DAILY AMINOGLYCOSIDE MONITORING Order a random level 8-10 after the beginning of the infusion. Please communicate with the nursing staff. Plot the level on the nomogram below based on when it was drawn. Nomogram for Gentamicin & at 7mg/kg**: If the point is near the line, the longer interval is chosen to avoid drug accumulation and provide sufficient drug-free period. If the random level is off (i.e., above) the nomogram between the 6- and 14- hr time points, the scheduled therapy is discontinued and the drug concentration is monitored to determine appropriate time of the next dose (i.e,concentration of <1 µg/ml) If level falls in area designated, the dosing interval is (the same applies for the areas q36h and ) Adopted from Hartford Hospital **: Divide amikacin level by 2 and plot above TIPS ON EVALUATING LEVELS AND REPEAT MONITORING: If the level falls on a line, the longer dosage interval should be selected. If the level falls above the Q 48H line: The drug should be held. o Serial random levels should be followed until <1mcg/mL If initial level falls below the nomogram, consider going to traditional dosing Repeat serum AG levels as necessary, with significant changes in CrCl or when therapy continues beyond 96 after previous level and every 96 to minimize toxicity. Patients on concurrent nephrotoxic agents (diuretics, vancomycin, contrast, etc) o Recommend monitor level twice a week and monitor BUN and Cr daily CrCl (ml/min) Traditional Aminoglycoside Dosing Gentamicin**/ **For Gram-positive endocarditis, use 1mg/kg Monitoring Traditional Dosing Gentamicin/ > 60 1-2mg/kg every 8 5mg/kg every 8 Target Peaks/Troughs: 40-60 20-40 <20 1-2mg/kg every 12 1-2mg/kg every 24 1-2mg/kg every 48 5mg/kg every 12 5mg/kg every 24 5mg/kg loading dose, then monitor levels <10 1-2mg/kg after HD 5mg/kg after HD Sepsis/Pneumonia: 7-10/ <2 OB-GYN: 5-7/ <2 **Synergy for Enterococcal or Streptococcal Endocarditis (Gent 1mg/kg): 2-4/ <1 Target Peaks/Troughs: Sepsis/Pneumonia: 20-30/ <10 UTI/Cystitis: 10-15/ <7 5/ <7